BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 829491)

  • 1. Evaluation of five mediums for the stabilization of Brucella abortus strain 19 dessicated by lyophilization.
    Angus RD; Love EL; Pietz DE
    Dev Biol Stand; 1976 Oct; 36():307-12. PubMed ID: 829491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of Brucella abortus strain RB51 lyophilized and as liquid vaccine under different storage conditions.
    Capsel RL; Olsen SC; Cheville NF; Thoen CO
    Biologicals; 2000 Dec; 28(4):209-15. PubMed ID: 11237356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the stability of Brucella abortus strain 19 reduced dosage lyophilized vaccines produced by different methods.
    Angus RD
    Dev Biol Stand; 1984; 56():659-78. PubMed ID: 6436119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Freeze-drying of brucella vaccine strain B 19.
    Valette L; Stellmann C; Précausta P; Desmettre P; Le Pemp M
    Dev Biol Stand; 1976 Oct; 36():313-22. PubMed ID: 829492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of temperature and degree of vacuum on the conservation of freeze-dried Brucella abortus strain 19 vaccine].
    García-Carrillo C
    Zentralbl Veterinarmed B; 1982 Feb; 29(1):57-66. PubMed ID: 6807032
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cell survival of the Brucella abortus strain 19 vaccine during the lyophilization process according to the vehicle used].
    García-Carrillo C
    Rev Argent Microbiol; 1981; 13(1):31-4. PubMed ID: 6810408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Greater attenuation of the virulence of Brucella abortus 19 with preservation of its immunogenicity].
    León AP; Pérez C
    Rev Invest Salud Publica; 1973; 33(3-4):17-33. PubMed ID: 4208623
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the preparation of a lyophilized Brucella abortus live vaccine ("Buck 19"). 1. On the effect of various stabilizators on the number of live cells].
    Boden W
    Arch Exp Veterinarmed; 1965 Apr; 19(1):281-7. PubMed ID: 4953584
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of temperature on preservation of brucella vaccines].
    Pilet C; le Garrec Y; Vissac JL; Lanneluc B; Garrido-Calderon N
    Dev Biol Stand; 1976; 31():314-22. PubMed ID: 1261745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of the sterilization technic and culture media components on the growth and dissociation of Brucella abortus strain 19 in submerged cultures].
    Yantorno OY; Mazza LA; Balatti AP; Aguirre W
    Rev Asoc Argent Microbiol; 1978; 10(3):83-93. PubMed ID: 119282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of Brucella abortus strain RB51 vaccine in pregnant cattle.
    Palmer MV; Olsen SC; Cheville NF
    Am J Vet Res; 1997 May; 58(5):472-7. PubMed ID: 9140553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Selection of diluents suitable for freeze-dried living vaccines of Brucella abortus Buck 19 and Erysipelothrix insidiosa].
    Boden W
    Monatsh Veterinarmed; 1967 May; 22(9):382-7. PubMed ID: 4969780
    [No Abstract]   [Full Text] [Related]  

  • 14. The chemical basis of the virulence of Brucella abortus. IX. The increased immunogenicity of Br. abortus grown in media which enhance its ability for survival within bovine phagocytes.
    Keppie J; Witt K; Smith H
    Br J Exp Pathol; 1969 Jun; 50(3):219-22. PubMed ID: 4978351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-exposure serological and bacteriological responses of water buffalo (Bubalus bubalis) to Brucella abortus biovar 1 following vaccination with Brucella abortus strain RB51.
    Diptee MD; Asgarali Z; Campbell M; Fosgate G; Adesiyun AA
    Rev Sci Tech; 2007 Dec; 26(3):669-78. PubMed ID: 18293615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses and efficacy after administration of a commercial Brucella abortus strain RB51 vaccine to cattle.
    Olsen SC
    Vet Ther; 2000; 1(3):183-91. PubMed ID: 19757581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phenol-insoluble vaccine against human brucellosis: evaluation of the immunogenic power in guinea pigs].
    Bolpe J; de Lapenta DF; García-Carrillo C
    Rev Inst Med Trop Sao Paulo; 1991; 33(1):23-7. PubMed ID: 1843392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Trials of the use of live vaccines against brucellosis and listeriosis in farm animals].
    Titov VV
    Arch Exp Veterinarmed; 1980; 34(1):115-8. PubMed ID: 6774688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Brucella abortus (strain 544) variants.
    Hopkins IG; Thornton DH; Hebert CN
    J Biol Stand; 1981 Oct; 9(4):421-9. PubMed ID: 6798039
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of Brucella abortus S19 vaccine strains by bacteriological tests, molecular analysis of ery loci and virulence in BALB/c mice.
    Mukherjee F; Jain J; Grilló MJ; Blasco JM; Nair M
    Biologicals; 2005 Sep; 33(3):153-60. PubMed ID: 16081301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.